# Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

> **NCT05754047** · — · COMPLETED · sponsor: **Mahdis Bayat** · enrollment: 3582 (actual)

## Conditions studied

- HER2 Low Breast Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** immunohistochemistry (IHC) and in situ hybridization (ISH) Test

## Key facts

- **NCT ID:** NCT05754047
- **Lead sponsor:** Mahdis Bayat
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1991-04
- **Primary completion:** 2022-03
- **Final completion:** 2022-03
- **Target enrollment:** 3582 (ACTUAL)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754047, "Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05754047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*